BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Stock Information for Atossa Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Atossa Therapeutics Inc.

CSE Bulletin: Delist - BioHarvest Sciences Inc. (BHSC)
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
CSE Bulletin: NV Issuer Designation - BioHarvest Sciences Inc. (BHSC)
BioHarvest Issues Shareholder Letter and Provides Corporate Update
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology
BioHarvest Sciences Reports Third Quarter 2024 Financial Results
BioHarvest Launches VINIA SuperFood Functional Tea Line

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.